Skip to main content

Harmony Biosciences Holdings, Inc 10-Q for FY2024 Q3

Harmony Biosciences Holdings, Inc. (HRMY)

10-Q 2024-10-29 For: 2024-09-30
View Original
Added on April 04, 2026

About this 10-Q

Harmony Biosciences Holdings, Inc filed this 10-Q on October 29, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$186.04M
up 16.1% from $160.27M a year earlier
Net income
$46.09M
up 19.8% from net income of $38.46M a year earlier
Diluted EPS
$0.79
up 25.4% from $0.63 a year earlier